EMMAUS LIFE SCIENCES, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $309.00K, a 69.10% decline year-over-year.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $1.00M.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $500.00K.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-06-30 was $797.90K.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $72.00K, a 76.70% decline from fiscal 2024.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $309.00K, a 92.41% decline from fiscal 2023.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $4.07M.
- EMMAUS LIFE SCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $6.32M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $72.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $309.00K 10-K · filed 2026-03-31 | |
| 2024-06-30 | $309.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $4.07M 10-K · filed 2025-04-14 | |
| 2023-06-30 | $1.00M 10-Q · filed 2024-11-19 | |
| 2023-03-31 | $500.00K 10-Q · filed 2024-11-19 | |
| 2016-09-30 | $6.32M 10-K · filed 2016-12-22 | |
| 2013-06-30 | $797.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | |
| 2012-09-30 | $1.90K 10-K · filed 2013-12-23 |